BiomX Inc.

06/28/2022 | Press release | Distributed by Public on 06/27/2022 23:44

8K-Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis